6:00 PM
 | 
Jun 04, 2013
 |  BC Extra  |  Top Story

Akebia raises $41 million series C

Anemia company Akebia Therapeutics Inc. (Cincinnati, Ohio) raised $41 million in a series C round co-led by new investors Satter Investment Management and Novo A/S. Existing investors Novartis Venture...

Read the full 128 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >